Nano-SnCl.SiO, an efficient catalyst for synthesis of benzimidazole drivatives as antifungal and cytotoxic agents.
Clicks: 217
ID: 96097
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
2.4
/100
8 views
8 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
The concept of green chemistry has made significant impact on many frontages including the use of green solvents or sustainable catalyst materials. Benzimidazole ring is an important nitrogen-containing heterocyclic, which exhibits a broad spectrum of bioactivities and are widely utilized by the medicinal chemists for drug discovery. A simple and efficient method was developed for the synthesis of some benzimidazole derivatives reaction of -phenylenediamine and substituted aldehydes in the presence of nano-SnCl/SiO as a mild catalyst. Ten 2-substituted benzimidazole compounds ( ) were synthesized. All compounds were evaluated against different species of yeasts and filament fungi using broth micro dilution method as recommended by clinical and laboratory standard institute. Among these compounds, the active ones were chosen for their cytotoxic activities evaluation against MCF-7 and A549 cell lines using MTT method. Compound showed the best antifungal activity against all tested species. Compounds had also desirable antifungal activities. Our cytotoxic results were also similar to the antifungal activities except for which had no cytotoxic activity.
| Reference Key |
zamani2019nanosnclsioresearch
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Zamani, Leila;Faghih, Zeinab;Zomorodian, Kamiar;Mirjalili, Bi Bi Fatemeh;Jalilian, Asghar;Khabnadideh, Soghra; |
| Journal | research in pharmaceutical sciences |
| Year | 2019 |
| DOI |
10.4103/1735-5362.272536
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.